Загрузка...
A comprehensively revised strategy that improves the specific activity and long-term stability of clinically relevant (89)Zr-immuno-PET agents
Zirconium-89 is currently being used in numerous clinical trials involving monoclonal antibodies and positron emission tomography. This report describes a revised strategy that reduces preparation time while increasing the specific activity of clinically relevant immuno-PET agents. Additionally, it...
Сохранить в:
| Опубликовано в: : | Dalton Trans |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6192516/ https://ncbi.nlm.nih.gov/pubmed/30178793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c8dt01841c |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|